Skip to Main Content

Paper Details

Clinical Use of the Urine Biomarker [TIMP-2] ÿ [IGFBP7] for Acute Kidney Injury Risk Assessment.
Am J Kidney Dis
141
2016
AKI, Acute Kidney Injury, Acute kidney injury, IGFBP7, TIMP-2, cell, creatinine, critically ill, insulin-like growth factor binding protein 7, kidney injury, patients
Acute Kidney Injury, Biomarkers, Clinical Trials as Topic, Decision Trees, Early Diagnosis, Humans, Insulin-Like Growth Factor Binding Proteins, Risk Assessment, Tissue Inhibitor of Metalloproteinase-2
Author NameAffiliation
Anitha VijayanWashington University in St. Louis
Sarah FaubelUniversity of Colorado Denver and Denver VA Medical Center
David J AskenaziUniversity of Alabama at Birmingham
Jorge CerdaAlbany Medical College
William H FissellVanderbilt University
Michael HeungUniversity of Michigan ann arbor
Benjamin D HumphreysWashington University in St. Louis
Benjamin D HumphreysWashington University in St. Louis
Jay L KoynerUniversity of Chicago
Kathleen D LiuUniversity of California san francisco
Girish MourUniversity of Pittsburgh
Thomas D NolinDepartment of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy
Azra BihoracUniversity of Florida
Azra BihoracUniversity of Florida
  • 1 - 14

Datasets

Release 1.2